S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects
The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Background S-adenosyl-L-methionine is an effective treatment for clinical depression, although the mechanism underlying this effect is unclear. Presently, in vivo phosphorus magnetic resonance spectroscopy (31P MRS) and brain transverse relaxometry were employed to test if S-adenosyl-L-methionine supplementation alters brain bioenergetics and/or transverse relaxation time (T2RT) in a nondepressed cohort. If these magnetic resonance techniques are sensitive to S-adenosyl-L-methionine induced alterations in neurochemical processes, these methods may be used in cases of clinical depression to elucidate the mechanism underlying the antidepressant effect of S-adenosyl-L-methionine.Methods Twelve subjects self-administered 1600 mg of oral S-adenosyl-L-methionine daily. Phosphorus spectra and transverse relaxation time were acquired at baseline and after treatment using a 1.5 Tesla scanner.Results Phosphocreatine levels were significantly higher after treatment, whereas beta nucleoside triphosphate levels, predominantly adenosine triphosphate in brain, were significantly lower after treatment. A surprising gender difference in T2RT emerged after supplementation, with women exhibiting significantly lower T2RT than men.Conclusions Alterations in phosphocreatine and beta nucleoside triphosphate are consistent with the report that S-adenosyl-L-methionine is involved in the production of creatine, which in turn is phosphorylated to phosphocreatine using adenosine triphosphate. These findings suggest that S-adenosyl-L-methionine alters parameters associated with cerebral bioenergetic status and that some effects of S-adenosyl-L-methionine (T2RT) occur in a gender-specific manner.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Reports since the early 1980s have suggested that creatine metabolism and/or availability may have antidepressive effects [312,313,314,315,316,317,318].”
From Creatine in health and disease (2021) · cites this paper as [316]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
The Structured Clinical Interview for DSM-III-R (SCID): I: History, Rationale, and Description
Spitzer, R. L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080032005 · Cited by 4,336
J Neuropsychiatry Clin Neurosci
Yudofsky, S. C., & Hales, R. E. (1992) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.4.4.359 · Cited by 3,818
Creatine and Creatinine Metabolism
Wyss, M., & Kaddurah-Daouk, R. (2000) · Physiological Reviews · doi:10.1152/physrev.2000.80.3.1107 · Cited by 2,950
Magnetic Resonance Imaging: Physical Principles and Sequence Design
Brown, R. W., Cheng, Y. N., Haacke, E. M., Thompson, M. R., & Venkatesan, R. (2014) · doi:10.1002/9781118633953 · Cited by 2,688
The Effects of Changes in Pa CO 2 Cerebral Blood Volume, Blood Flow, and Vascular Mean Transit Time
GRUBB, R. L., RAICHLE, M. E., EICHLING, J. O., & TER-POGOSSIAN, M. M. (1974) · Stroke · doi:10.1161/01.str.5.5.630 · Cited by 1,044
THE CREATINE-CREATINE PHOSPHATE ENERGY SHUTTLE
Bessman, S. P., & Carpenter, C. L. (1985) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.54.070185.004151 · Cited by 772
Cerebral intracellular pH by 31 P nuclear magnetic resonance spectroscopy
Petroff, O. A. C., Prichard, J. W., Behar, K. L., Alger, J. R., den Hollander, J. A., & Shulman, R. G. (1985) · Neurology · doi:10.1212/wnl.35.6.781 · Cited by 525
van Zijl, P. C. M., Eleff, S. M., Ulatowski, J. A., Oja, J. M. E., Uluǧ, A. M., Traystman, R. J., & Kauppinen, R. A. (1998) · Nature Medicine · doi:10.1038/nm0298-159 · Cited by 501
Research works printed but not linked: 1
- Estilaei, 2001, Effects of chronic alcohol consumption on the broad phospholipid signal in human brain, Alcohol Clin Exp Res, 25, 89, 10.1111/j.1530-0277.2001.tb02131.x · doi:10.1111/j.1530-0277.2001.tb02131.x
Cited by
Creatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
“[316] reported that SAMe supplementation (1600 mg/day) increased brain creatine and PCr levels and lowered transverse relaxation time (T2RT) using magnetic resonance spectroscopy (31P MRS) in nondepressed subjects; this effect was larger in women compared to men.”
BackgroundDiet and the epigenetic (re)programming of phenotypic differences in behavior
McGowan, P. O., Meaney, M. J., & Szyf, M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.074 · Cited by 214
Brain Bioenergetics and Response to Triiodothyronine Augmentation in Major Depressive Disorder
Iosifescu, D. V., Bolo, N. R., Nierenberg, A. A., Jensen, J. E., Fava, M., & Renshaw, P. F. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.020 · Cited by 139
Lyoo, I. K., Yoon, S., Kim, T.-S., Hwang, J., Kim, J. E., Won, W., Bae, S., & Renshaw, P. F. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010009 · Cited by 123
“S-Adenosyl-L-methionine, which is a methyl donor in the production of creatine (10) and exerts robust antidepressant efficacy, particularly in SSRI-resistant major depression (30), may be similar to creatine in terms of increasing phosphocreatine levels in the brain (31).”
BackgroundCreatine monohydrate in resistant depression: A preliminary study
Roitman, S., Green, T., Osher, Y., Karni, N., & Levine, J. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00532.x · Cited by 118
Metadata
- Authors
- Silveri, M. M., Parow, A. M., Villafuerte, R. A., Damico, K. E., Goren, J., Stoll, A. L., Cohen, B. M., & Renshaw, P. F.
- Affiliations
- Harvard University (US)
- McLean Hospital (US)
- Corresponding author
- Silveri, Marisa M.
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2003-10
- Volume
- 54
- Issue
- 8
- Pages
- 833-839
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1969014186
- Cited by
- 35
- References
- 48
- Citations by year
- 2026: 2 · 2024: 2 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2014: 2 · 2013: 3 · 2012: 1
- FWCI
- 1.29
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (MH-58681, R01MH058681)
- National Institute on Drug Abuse (K24DA015116, DA15116, DA-09448, R01DA009448)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced NMR Techniques and Applications
- Keywords
- S-adenosylmethionine, brain bioenergetics, T2 relaxation time, phosphocreatine, adenosine triphosphate, creatine synthesis, gender differences, antidepressant mechanism, 31P NMR, healthy volunteers
- MeSH terms
- Adenosine Triphosphate, Administration, Oral, Adult, Antidepressive Agents, Brain, Cerebrovascular Circulation, Major Depressive Disorder, Drug Administration Schedule, Energy Metabolism, Female, Health Status, Humans, Male, Models, Biological, Magnetic Resonance Spectroscopy, Phosphocreatine, Phosphorus, Relaxation, S-Adenosylmethionine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. https://app.cochat.ai/papers/10.1016/s0006-3223(03)00064-7
- The paper
- Silveri, M. M., Parow, A. M., Villafuerte, R. A., Damico, K. E., Goren, J., Stoll, A. L., Cohen, B. M., & Renshaw, P. F. (2003). S-adenosyl-l-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects. Biological Psychiatry. https://doi.org/10.1016/s0006-3223(03)00064-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.